EdiGene
3 known investors
EdiGene is a biotechnology company developing genome-editing-based therapies, including allogeneic cell therapies and in vivo RNA base editing platforms, alongside a high-throughput genome editing screening platform. It focuses on treatments for genetic diseases and cancer.
BiotechDeep TechHealthtech
Investors · 3
Frequently asked questions
- What does EdiGene do?
- EdiGene is a biotechnology company developing genome-editing-based therapies, including allogeneic cell therapies and in vivo RNA base editing platforms, alongside a high-throughput genome editing screening platform. It focuses on treatments for genetic diseases and cancer.
- Who are EdiGene's investors?
- EdiGene's investors include LAV, Lilly Asia Ventures, WI Harper Group.